Aspen Aerogels (ASPN) last issued guidance on May 7, 2026 for Q2 2026. The company guided earnings per share in the range of $-0.24 - $-0.17, compared to a consensus EPS estimate of $-0.21. Aspen Aerogels also guided revenue in the range of $40.00M - $48.00M for the period.
Compared to prior guidance, Aspen Aerogels raised its revenue forecast from a prior range of $35.00M - $40.00M.
Aspen Aerogels has issued 20 guidance updates between June 6, 2022 and May 7, 2026. During this period, the company raised its outlook 7 times and lowered it 8 times, providing investors with insight into management's evolving expectations.
Review all historical guidance issued by Aspen Aerogels, including EPS and revenue forecasts across quarterly and annual periods.
The most recent guidance for Aspen Aerogels (ASPN) was reported on May 7, 2026 for Q2 2026. The company provided earnings per share guidance in the range of $-0.24 to $-0.17, compared to the estimated EPS of $-0.21. Additionally, Aspen Aerogels forecasted revenue between $40.00M and $48.00M for the period.
Aspen Aerogels (ASPN) guided EPS in the range of $-0.24 to $-0.17 for Q2 2026. The consensus analyst EPS estimate is $-0.21.
Aspen Aerogels (ASPN) guided revenue in the range of $40.00M to $48.00M for Q2 2026.
Aspen Aerogels (ASPN) raised its revenue guidance from a prior range of $35.00M - $40.00M to $40.00M - $48.00M for Q2 2026.
Aspen Aerogels (ASPN) last issued guidance on May 7, 2026 for Q2 2026.